Enzyme-Linked Immunosorbent Assay Testing Market

ELISAs (Enzyme-linked immunosorbent assays) are routinely used for the qualitative and quantitative assessment of cytokines, chemokines, growth factors, phosphorylated targets, immunoglobulins and other immunological markers. Detection and quantitation of protein analytes from various biological samples?serum, plasma, cell culture supernatants and cell lysates?indicate a multitude of biological and pathological events. ELISAs have proven to be valuable tools in drug development as they are commonly used for biomarker profiling of disease vs. normal states, as well as toxicity profiling.
Enzyme-Linked Immunosorbent Assay Testing Market aims to provide a comprehensive presentation of the global market for Enzyme-Linked Immunosorbent Assay (Elisa) Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Enzyme-Linked Immunosorbent Assay (Elisa) Testing. Enzyme-Linked Immunosorbent Assay Testing Market contains market size and forecasts of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in global, including the following market information:
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market was valued at US$ 184.2 million in 2022 and is projected to reach US$ 233.5 million by 2030, at a CAGR of 3.4% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global Enzyme-Linked Immunosorbent Assay (ELISA) key players include R&D Systems, Thermo Fisher Scientific, Ortho Clinical Diagnostics, BD Biosciences, etc. Global top four manufacturers hold a share over 45%.
China is the largest market, with a share over 35%, followed by Europe, and USA, both have a share over 30 percent.
In terms of product, Indirect ELISA is the largest segment, with a share over 45%. And in terms of application, the largest application is Immunology, followed by Infectious Diseases, Protein Quantitation, Cancer, etc.
We surveyed the Enzyme-Linked Immunosorbent Assay (Elisa) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Segment Percentages, by Type, 2022 (%)
Sandwich ELISA
Indirect ELISA
Multiple and portable ELISA
Competitive ELISA
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Segment Percentages, by Application, 2022 (%)
Immunology
Inflammation
Infectious diseases
Cancer
Protein quantitation
Other
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Enzyme-Linked Immunosorbent Assay (Elisa) Testing revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Ortho-Clinical Diagnostics, Inc.
Thermo Fisher Scientific. Inc.
Life Technologies Corporation
ZEUS Scientific, Inc.
R & D Systems (a Biotechne brand)
Abbexa
Abcam
Abelisa
Abnova
Bhat Bio-tech
Bio-Rad Laboratories
Biorbyt
Calbiotech
Cayman Chemicals
Crystal Chem
Diagenics
Eagle Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Enzyme-Linked Immunosorbent Assay (Elisa) Testing, market overview.
Chapter 2: Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing market size in revenue.
Chapter 3: Detailed analysis of Enzyme-Linked Immunosorbent Assay (Elisa) Testing company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Enzyme-Linked Immunosorbent Assay (Elisa) Testing in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.